Prevalence and impact of fertility concerns in young women with breast cancer
Samantha Mannion, Alexandra Higgins, Nicole L. Larson, Elizabeth A. Stewart, Zaraq Khan, Chandra C. Shenoy, Hazel B. Nichols, H. Irene Su, Ann H. Partridge, Charles L. Loprinzi, Fergus J. Couch, Janet E. Olson, Kathryn J. Ruddy
Abstract
Survey data from the Mayo Clinic Breast Disease Registry were used to assess fertility counseling and fertility preservation strategies in a modern cohort of young women with breast cancer. One hundred respondents were identified who were under age 50 at the time of breast cancer diagnosis and who expressed interest in future childbearing near the time of diagnosis and/or 1 year later. Ninety-three percent of the 81 respondents to the year one survey recalled fertility counseling prior to cancer treatment. Most who reported a high level of fertility concern declared that this concern had impacted their treatment decisions, often shortening their planned duration of endocrine therapy. Approximately half had taken steps to preserve future fertility, and a third had used a gonadotropin-releasing hormone agonist either alone or combined with another method (e.g., embryo or oocyte cryopreservation).